What Happened?
Cambridge, -based Sarepta Promoted Ryan Brown as Interim General Counsel
Date of management change: December 14, 2020
Cambridge, -based Sarepta Promoted Ryan Brown as Interim General Counsel
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.
Ryan Brown is Interim General Counsel at Sarepta. Previously, Ryan held various senior legal leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Novak Jeannine, Jocelyn Cynthia, Hochgesang Ryan, Paterson Guthrie, Gruber Julie, McFarland Shannon, Rubenfeld Eric, Smith Phillip, Jackson Devina, Weeter Heather, Strohm Leslie
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.